EM A n I Flashcards
rash shown in the picture is urticaria. Urticaria following use of a drug, especially penicillin, is often due to
IgE-mediated reactions.
IgE is fixed to mast cells and with cross-linking by a specific antigen, potent vasodilator substances like histamine and leukotrienes are released. The result is urticaria, swelling and edema in the epidermis. Angioedema, edema and swelling at the dermoepidermal junction and subcutaneous tissues, results from the same mechanism. This type of reaction is often called a Type I hypersensitivity.
Type II hypersensitivity is mediated by
cytotoxic antibodies. These antibodies are formed in response to an environmental antigen or a self-antigen. Upon subsequent exposure, the antigen may attach to a cell and result in binding of the antibody to the attached antigen. Complement activation begins, resulting in cell damage or destruction. An example of a Type II mediated response is a drug-induced hemolytic anemia.
These immune complexes lodge in small vessels and tissues, primarily skin, joints, and lung. This activates the serum complement cascade, releasing enzymes and prostaglandins. Serum sickness is the classic example of a
Type III hypersensitivity. An IgG-mediated response occurs mostly with injected antigens or occasionally with ingested substances. It is also called a Type III hypersensitivity and results from antigen-antibody immune complex formation.
A deficiency of C1 esterase inhibitor results in
hereditary angioedema. This is an autosomal dominant condition. The deficiency leads to spontaneous complement activation and can have life-threatening consequences due to laryngeal edema. The diagnosis is made by measurement of C1 esterase inhibitor levels.
A cell-mediated reaction (Type IV hypersensitivity) does not involve antibody; rather, it involves
T-lymphocytes. The cell has a specific receptor for an antigen, and after the initial exposure, the cells will proliferate and change into natural killer cells and/or recruiting cells. Examples of this type of hypersensitivity include graft-versus-host response and tuberculin skin tests.
Treatment of immunocompromised patients with primary varicella infections due to the high risk of disseminated disease and complications from infection.
High doses of IV acyclovir (500 mg/m2 IV every 8 hours)
To prevent primary varicella infection in susceptible patients who have been exposed to the virus,
varicella zoster immune globulin (VZIG) needs to be administered within 96 hours of exposure and sooner, if possible, for maximum effectiveness.
Varicella vaccination should not be administered to
persons receiving high dose systemic steroids and should not be given concurrently with VZIG
13-year old child has recurrent pulmonary infections. All childhood immunizations have been received as scheduled. Results of laboratory studies, including blood counts, plasma immunoglobulins, and sweat test, are within normal limits. Intradermal injection of 1:5 dilution of tetanus toxoid does not lead to an erythematous, indurated lesion during the next 3 days.
Impaired T cell function which needs further investigation
Recurrent pulmonary infections warrant thorough laboratory investigation, including blood counts, sedimentation rate, plasma immunoglobulins, and sweat test. In addition, skin test responses are helpful in
assessing T lymphocyte function.
Delayed hypersensitivity, a type IV hypersensitivity reaction, depends on the
the intact functioning of T cells. A variety of antigens, to which most older children and adults have been exposed, can be used for testing: purified protein derivative (PPD), histoplasmin, candidin (most people have been exposed to this yeast antigen), and mumps antigen. Intradermal injection of tetanus toxoid is particularly useful. Positive test is indicated by an erythematous, indurated lesion that peaks after 48 hours.
Patients with complement deficiencies have
normal white blood cell and neutrophil counts and function.
Deficiency of the membrane attack complex or properdin, which stabilizes the alternative C3 convertase, tend to manifest in
recurrent Neisseria infections.
teenager shows typical symptoms of allergic rhinitis, a type I immediate hypersensitivity reaction. IgE is only 0.004% of total serum immunoglobulins, but binds with high affinity to mast cells and basophils through a site in the Fc region. In the phase of sensitization, allergen specific IgE binds to high-affinity Fc receptors on mast cells and basophils. Production of IgE antibodies is driven by the production of IL-4 by helper CD4 T cells (TH2 cells). The symptoms are caused by
a re-exposure release of active mediators, following antigens reacting with mast cell bound IgE. Antibody reaction with cell-bound antigen is a type II hypersensitivity reaction. Immune-complex disease is a local tissue damage caused by antigen-antibody complexes. Hypersensitivity disorder, caused by the presence of persistent antigen within macrophages, is a typical type IV delayed hypersensitivity reaction.
Antihistamines, like diphenhydramine,
block histamine mediator binding to target tissue.